USPTO serial 79436736
VASCVERSA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- LAWRENCE, SUSAN KASTRINER
- Law office
- TMO LAW OFFICE 116
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with VASCVERSA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Stem cells for research purposes; stem cells for scientific purposes; chemicals for use in manufacturing pharmaceuticals; reagents for research purposes; reagents for medical research; reagents for scientific purposes; diagnostic reagents for scientific or research use; cell culture reagents for scientific and research use; blood culture media for scientific use. | ACTIVE | — |
| 005 | Pharmaceuticals; drugs for medical purposes; stem cells; pharmaceutical preparations containing stem cells; stem cells for medical purposes; cells for medical use; cell growth media for growing cells for medical use; living cells for medical use; cellular function activating agents for medical purposes; vaccines, reagents for medical use; medical diagnostic reagents; biological tissue cultures for medical purposes; human allograft tissue; tissues for medical use; vascular grafts; sponges for healing wounds. | ACTIVE | — |
| 010 | Medical devices; medical apparatus; medical instruments; apparatus for the regeneration of stem cells for medical purposes; medical devices and apparatus for vascular regeneration and repair; medical devices and apparatus for cell therapy; blood testing equipment; blood testing apparatus; artificial vascular grafts. | ACTIVE | — |
| 042 | Medical and pharmacological research services; stem cell research; scientific services relating to the isolation and cultivation of human tissues and cells; research in the field of cell engineering technology; research in the field of vascular regeneration and repair; research and development of medicines; pharmaceutical drug development services; drug discovery services; development of pharmaceutical preparations and medicines; development of cell therapies; research and development services in the medical field of cell therapy; research and development services in the medical field of vascular regeneration and repair; clinical trials; blood analysis services; gene therapy research; information, advisory and consultancy services in relation to all of the aforesaid services. | ACTIVE | — |
| 044 | Regenerative medicine services; medical services; stem cell therapy services; cell therapy services; cell therapy services for vascular regeneration and repair; cell therapy services relating to the generation of human vascular reparative cells; cell therapy services relating to the injecting, grafting or implanting of cells into patients; medical services relating to the removal, treatment and processing of cells; medical services relating to the removal, treatment and processing of stem cells; stem cell storage; human cell storage; cultured cell bank services for medical transplantation; medical laboratory services for the analysis of samples taken from patients; medical analysis services; services for the testing of blood; medical services relating to the removal, treatment and processing of human blood; information, advisory and consultancy services in relation to all of the aforesaid services. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by VASCVERSA LIMITED
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named VASCVERSA
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2026 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 1, 2026 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 2, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 17, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 17, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 5, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 12, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 11, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 4, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 17, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 17, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 13, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |